MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$82,908K
Short-term royalty and
commercial payment...
$22,780K
Short-term restricted cash
$5,441K
Trade and other
receivables, net
$4,896K
Prepaid expenses and
other current assets
$852K
Investment in equity
securities
$382K
Total current assets
$117,259K
Long-term royalty and
commercial payment...
$55,888K
Long-term restricted cash
$45,361K
Intangible assets, net
$44,756K
Long-term royalty and
commercial payment...
$4,433K
Exarafenib milestone asset
(note 6)
$3,600K
Investment in warrants
$697K
Other assets - long
term
$427K
Operating lease
right-of-use assets
$256K
Property and equipment,
net
$21K
Total assets
$272,698K
Total liabilities,
convertible preferred stock...
$272,698K
Total liabilities
$168,738K
Total stockholders'
equity
$83,941K
Convertible preferred
stock, 0.05 par value,...
$20,019K
Accumulated deficit
-$1,221,450K
Long-term debt
$96,451K
Total current
liabilities
$34,820K
Long-term operating lease
liabilities
$20,114K
Contingent value rights
liabilities - long-term
$10,457K
Exarafenib milestone
contingent consideration...
$3,600K
Unearned revenue
recognized under...
$3,193K
Deferred tax liability
$103K
Additional paid-in capital
$1,305,200K
Common stock, 0.0075
par value,...
$89K
Accumulated other
comprehensive income
$53K
Preferred stock
$49K
Current portion of
long-term debt
$12,526K
Accrued and other
current liabilities
$9,885K
Contingent value rights
liabilities - current...
$5,045K
Operating lease
liabilities
$2,464K
Accounts payable
$2,208K
Preferred stock dividend
accrual
$1,424K
Unearned revenue
recognized under...
$1,268K
Back
Back
Balance Sheet
source: myfinsight.com
XOMA Royalty Corp (XOMA)
XOMA Royalty Corp (XOMA)